We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$18B
AUM Growth
+$691M
Cap. Flow
-$118M
Cap. Flow %
-0.66%
Top 10 Hldgs %
48.77%
Holding
1,502
New
63
Increased
171
Reduced
472
Closed
89

Top Sells

Rank Stock Value
1
OPLN
Openlane
OPLN
+$100M
2
ARMK icon
Aramark
ARMK
+$99.9M
3
WFC icon
Wells Fargo
WFC
+$53.8M
4
ARWR icon
Arrowhead Research
ARWR
+$40.5M
5
AAPL icon
Apple
AAPL
+$32M

Sector Composition

Rank Sector Weight
1 Financials 40.77%
2 Technology 11.02%
3 Healthcare 10.71%
4 Consumer Discretionary 8.5%
5 Communication Services 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
126
CVS Health
CVS
$137B
$14.2M 0.08%
259,725
-332,601
-56% -$17.9M
OXY icon
127
Occidental Petroleum
OXY
$57B
$14M 0.08%
278,800
+93,724
+51% +$5.27M
VBTX
128
DELISTED
Veritex Holdings
VBTX
$13.9M 0.08%
535,941
+10,650
+2% +$276K
EOG icon
129
EOG Resources
EOG
$78B
$13.9M 0.08%
148,723
-14,409
-9% -$1.34M
EVRG icon
130
Evergy
EVRG
$20.1B
$13.9M 0.08%
230,315
-4,497
-2% -$263K
VOO icon
131
Vanguard S&P 500 ETF
VOO
$968B
$13.8M 0.08%
51,126
+317
+0.6% +$83.9K
MLM icon
132
Martin Marietta Materials
MLM
$33.6B
$13.8M 0.08%
59,766
-2,200
-4% -$477K
STAY
133
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$13.7M 0.08%
813,468
VYNE icon
134
VYNE Therapeutics
VYNE
$340K
$13.3M 0.07%
30,919
-427
-1% -$211K
T icon
135
AT&T
T
$165B
$13.1M 0.07%
519,458
-92,433
-15% -$2.22M
CSWC icon
136
Capital Southwest
CSWC
$1.46B
$13.1M 0.07%
625,500
-9,402
-1% -$204K
L icon
137
Loews
L
$24.3B
$13.1M 0.07%
239,305
-5,589
-2% -$287K
TRV icon
138
Travelers Companies
TRV
$80.8B
$13M 0.07%
87,141
-1
-0% -$144
SRE icon
139
Sempra
SRE
$60.8B
$13M 0.07%
189,554
-3,600
-2% -$236K
COR icon
140
Cencora
COR
$60.3B
$13M 0.07%
152,274
-3,963
-3% -$313K
NWL icon
141
Newell Brands
NWL
$2.16B
$12.9M 0.07%
837,983
-87,109
-9% -$1.3M
LLY icon
142
Eli Lilly
LLY
$1.07T
$12.9M 0.07%
116,115
-100
-0.1% -$11.8K
CL icon
143
Colgate-Palmolive
CL
$72.6B
$12.6M 0.07%
175,310
+796
+0.5% +$56.5K
MKC icon
144
McCormick & Company Non-Voting
MKC
$13.4B
$12.5M 0.07%
161,100
-1,250
-0.8% -$96.4K
LSXMA
145
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$12.4M 0.07%
453,378
-2,876
-0.6% -$79.5K
ABBV icon
146
AbbVie
ABBV
$458B
$12.2M 0.07%
+168,293
New +$13.2M
YUM icon
147
Yum! Brands
YUM
$41B
$12.1M 0.07%
108,967
-7,125
-6% -$740K
PBH icon
148
Prestige Consumer Healthcare
PBH
$2.35B
$11.5M 0.06%
363,457
-7,555
-2% -$225K
IDXX icon
149
Idexx Laboratories
IDXX
$42.9B
$11.4M 0.06%
41,586
+37,461
+908% +$9.23M
META icon
150
Meta Platforms (Facebook)
META
$1.51T
$11.4M 0.06%
58,814
+4,010
+7% +$733K

Similar funds

First Manhattan's Q2 2019 Portfolio in Review

As of Q2 2019, First Manhattan held 1,502 positions worth $18B, up 4% from $17.3B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

First Manhattan's Q2 2019 filing shows 63 new, 171 increased, 472 reduced and 89 closed positions. Its largest new stake was IAA, Inc. Common Stock: 4,183,347 shares worth $162M. The largest sale was Openlane, an estimated $100M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q2 2019 buy was IAA, Inc. Common Stock: 4,183,347 shares worth $162M.
  • First Manhattan added most to Intercontinental Exchange in Q2 2019, an estimated $104M increase.
  • First Manhattan's biggest Q2 2019 reduction was Openlane, cutting an estimated $100M.
  • First Manhattan fully exited Natera in Q2 2019, selling an estimated $21.2M.
  • First Manhattan's ten largest holdings make up 49% of its $18B portfolio in Q2 2019.
  • First Manhattan opened 63 new positions and closed 89 in Q2 2019.
  • First Manhattan's portfolio value rose 4% quarter-over-quarter to $18B.

Based on First Manhattan's 13F filing for Q2 2019, filed 16 Aug 2019.